Original
Análisis coste-efectividad de sofosbuvir, interferón pegilado y ribavirina en pacientes con hepatitis crónica por virus C: tratamiento precoz en fases iniciales de fibrosis vs. tratamiento tardío en fases avanzadas
Cost-effectiveness analysis of sofosbuvir, peginterferon and ribavirin in patients with chronic hepatitis C: Early treatment in the initial stage of fibrosis vs. delayed treatment in advanced fibrosis
Leído
5086
Vecesse ha leído el artículo
877
Total PDF
4209
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 15 | 8 | 23 |
| 2025 11 | 48 | 26 | 74 |
| 2025 10 | 42 | 6 | 48 |
| 2025 9 | 41 | 22 | 63 |
| 2025 8 | 43 | 15 | 58 |
| 2025 7 | 47 | 6 | 53 |
| 2025 6 | 39 | 3 | 42 |
| 2025 5 | 43 | 5 | 48 |
| 2025 4 | 52 | 4 | 56 |
| 2025 3 | 62 | 8 | 70 |
| 2025 2 | 81 | 3 | 84 |
| 2025 1 | 58 | 7 | 65 |
| 2024 12 | 28 | 3 | 31 |
| 2024 11 | 46 | 3 | 49 |
| 2024 10 | 24 | 4 | 28 |
| 2024 9 | 30 | 5 | 35 |
| 2024 8 | 37 | 8 | 45 |
| 2024 7 | 32 | 4 | 36 |
| 2024 6 | 18 | 4 | 22 |
| 2024 5 | 27 | 3 | 30 |
| 2024 4 | 18 | 7 | 25 |
| 2024 3 | 34 | 7 | 41 |
| 2024 2 | 22 | 5 | 27 |
| 2024 1 | 30 | 1 | 31 |
| 2023 12 | 65 | 4 | 69 |
| 2023 11 | 46 | 7 | 53 |
| 2023 10 | 42 | 5 | 47 |
| 2023 9 | 22 | 2 | 24 |
| 2023 8 | 37 | 5 | 42 |
| 2023 7 | 18 | 5 | 23 |
| 2023 6 | 29 | 1 | 30 |
| 2023 5 | 21 | 6 | 27 |
| 2023 4 | 25 | 2 | 27 |
| 2023 3 | 30 | 4 | 34 |
| 2023 2 | 23 | 4 | 27 |
| 2022 1 | 57 | 6 | 63 |
| 2022 12 | 40 | 4 | 44 |
| 2022 11 | 43 | 15 | 58 |
| 2022 10 | 41 | 13 | 54 |
| 2022 9 | 44 | 16 | 60 |
| 2022 8 | 62 | 13 | 75 |
| 2022 7 | 44 | 18 | 62 |
| 2022 6 | 73 | 17 | 90 |
| 2022 5 | 88 | 9 | 97 |
| 2022 4 | 122 | 16 | 138 |
| 2022 3 | 287 | 15 | 302 |
| 2022 2 | 304 | 10 | 314 |
| 2021 1 | 158 | 12 | 170 |
| 2021 12 | 97 | 16 | 113 |
| 2021 11 | 166 | 12 | 178 |
| 2021 10 | 69 | 14 | 83 |
| 2021 9 | 40 | 9 | 49 |
| 2021 8 | 69 | 8 | 77 |
| 2021 7 | 28 | 4 | 32 |
| 2021 6 | 38 | 11 | 49 |
| 2021 5 | 42 | 11 | 53 |
| 2021 4 | 51 | 36 | 87 |
| 2021 3 | 36 | 12 | 48 |
| 2021 2 | 25 | 9 | 34 |
| 2020 1 | 47 | 12 | 59 |
| 2020 12 | 30 | 15 | 45 |
| 2020 11 | 48 | 15 | 63 |
| 2020 10 | 20 | 4 | 24 |
| 2020 9 | 28 | 14 | 42 |
| 2020 8 | 30 | 13 | 43 |
| 2020 7 | 32 | 10 | 42 |
| 2020 6 | 41 | 18 | 59 |
| 2020 5 | 29 | 13 | 42 |
| 2020 4 | 30 | 9 | 39 |
| 2020 3 | 31 | 5 | 36 |
| 2020 2 | 25 | 5 | 30 |
| 2020 1 | 19 | 4 | 23 |
| 2019 12 | 36 | 10 | 46 |
| 2019 11 | 15 | 8 | 23 |
| 2019 10 | 22 | 6 | 28 |
| 2019 9 | 29 | 24 | 53 |
| 2019 8 | 12 | 6 | 18 |
| 2019 7 | 23 | 20 | 43 |
| 2019 6 | 39 | 30 | 69 |
| 2019 5 | 113 | 28 | 141 |
| 2019 4 | 64 | 31 | 95 |
| 2019 3 | 10 | 4 | 14 |
| 2019 2 | 22 | 13 | 35 |
| 2019 1 | 8 | 5 | 13 |
| 2018 12 | 11 | 11 | 22 |
| 2018 11 | 15 | 2 | 17 |
| 2018 10 | 15 | 12 | 27 |
| 2018 9 | 33 | 0 | 33 |
| 2018 8 | 7 | 2 | 9 |
| 2018 4 | 0 | 1 | 1 |
| 2017 9 | 2 | 0 | 2 |
| 2017 4 | 1 | 0 | 1 |
| 2017 3 | 1 | 0 | 1 |
| 2016 1 | 0 | 1 | 1 |
| 2016 12 | 1 | 0 | 1 |
| 2016 11 | 3 | 1 | 4 |
| 2016 10 | 2 | 0 | 2 |
| 2016 9 | 3 | 2 | 5 |
| 2016 8 | 10 | 3 | 13 |
| 2016 7 | 3 | 2 | 5 |
Mostrar todo
